" class="no-js "lang="en-US"> News Archives - Medtech Alert
Tuesday, March 19, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients

Eloxx Pharmaceuticals, a leader in ribosomal RNA-targeted genetic therapies for rare diseases, have announced the […]

Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS

Verge Genomics, a clinical-stage biotechnology company transforming drug discovery using artificial intelligence and human data, […]

DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board

DEM BioPharma, an immune-oncology company developing therapies that target signals on cancer cells and myeloid […]

Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera

Confo Therapeutics, a leader in the discovery of medicines targeting G-protein coupled receptors (GPCRs), today […]

Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic

Vyriad announces an expansion of a Phase 1 investigator-initiated trial at Mayo Clinic evaluating the […]

Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders

Astellas Pharma and Cullgen have announced a research collaboration and exclusive option agreement to discover […]

Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program

Auxilius Pharma has consolidated its funding of $1 Million for developing its lead asset, AUX-001, […]

Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets

Captivate Bio and EverCell Bio are excited to announce a new collaboration to accelerate the development […]

Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies

Applied StemCell and the California Institute for Regenerative Medicine (CIRM) have partnered as Industry Resource […]

Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors

Alentis Therapeutics, the clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more